Immune system in the blood of Alzheimer's patients found to be epigenetically altered
A new Northwestern Medicine study has found the immune system in the blood of Alzheimer's patients is epigenetically altered.
Stay updated with breaking news from Bright Focus Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new Northwestern Medicine study has found the immune system in the blood of Alzheimer's patients is epigenetically altered.
A new study reveals epigenetic alterations in the immune system of Alzheimer's patients' blood, suggesting environmental or behavioral factors could influence Alzheimer's risk.
Since the Baby Boomers are transitioning into older age by 2040 and 2050, the dramatic rise in the global aging population will increase demands for ophthalmic care.
Glaucoma is one of the leading causes of blindness worldwide, and vision loss, due to the loss of retinal ganglion cells (RGCs), cannot currently be reversed with any treatment.
Research led by Nicolas Bazan, MD, PhD, Boyd Professor, Ernest C. and Yvette C. Villere Chair for the Study of Retinal Degeneration, and Director of the Neuroscience Center of Excellence at LSU Health New Orleans School of Medicine, suggests that age-related macular degeneration (AMD) decreases an essential fatty acid, preventing the formation of a class of protective molecules and reducing repair potential. The discovery may also open new therapeutic avenues for AMD.